Aplicability of the predictive model of response to erythropoetic stimulating agents (ESA) from myelodysplastic syndromes (MDS) and analysis of response and overall survival (OS) in a series of 99 patients (PTS) with chronic myelomonocytic leukemia (CMML)
Services
Services
Date issued
2013Journal title
Blood
Type of content
Publicación de congreso
